Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients

BACKGROUND: The use of oral ribavirin (RBV) for respiratory syncytial virus (RSV) infections is not well studied. With the drastic increase in the cost of aerosolized RBV, we aimed to compare outcomes of hematopoietic cell transplant (HCT) recipients treated with oral or aerosolized RBV for RSV infe...

Full description

Saved in:
Bibliographic Details
Published in:Clin Infect Dis
Main Authors: Foolad, Farnaz, Aitken, Samuel L, Shigle, Terri Lynn, Prayag, Amrita, Ghantoji, Shashank, Ariza-Heredia, Ella, Chemaly, Roy F
Format: Artigo
Language:Inglês
Published: Oxford University Press 2019
Subjects:
Articles and Commentaries
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7108094/
https://ncbi.nlm.nih.gov/pubmed/30202920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy760
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items